Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116210362 | 11621036 | 2 | F | 20110125 | 20160718 | 20151012 | 20160725 | EXP | US-DSJP-DSU-2015-120836 | DAIICHI | 0.00 | Y | 0.00000 | 20160725 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116210362 | 11621036 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40 MG, QD | 2280 | MG | Y | 21286 | 40 | MG | TABLET | QD | ||||
| 116210362 | 11621036 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG, QD | 2758.6592 | DF | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||
| 116210362 | 11621036 | 3 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG, QD | 2758.6592 | DF | Y | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||
| 116210362 | 11621036 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 25 MG, QD | 0 | 25 | MG | QD | ||||||||
| 116210362 | 11621036 | 5 | C | COREG | CARVEDILOL | 1 | 12.5 MG, BID | 0 | 12.5 | MG | BID | ||||||||
| 116210362 | 11621036 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 116210362 | 11621036 | 7 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | 625 MG, QD | 0 | 625 | MG | QD | ||||||||
| 116210362 | 11621036 | 8 | C | GLUMETZA | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, BID | 0 | 1000 | MG | BID | ||||||||
| 116210362 | 11621036 | 9 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | 60 MG, UNK | 0 | 60 | MG | |||||||||
| 116210362 | 11621036 | 10 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | 90 MG, UNK | 0 | 90 | MG | |||||||||
| 116210362 | 11621036 | 11 | C | MERCAPTOPURINE. | MERCAPTOPURINE | 1 | 75 MG, QD | 0 | 75 | MG | QD | ||||||||
| 116210362 | 11621036 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 116210362 | 11621036 | 13 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 14 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 15 | C | LOMOTIL /00384302/ | LOPERAMIDE HYDROCHLORIDE | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 116210362 | 11621036 | 16 | C | OXYCODONE AND ACETAMINOPHEN | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 17 | C | CHOLESTYRAMINE. | CHOLESTYRAMINE | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 18 | C | LOTRONEX /01482801/ | 2 | UNK | 0 | ||||||||||||
| 116210362 | 11621036 | 19 | C | ALIGN | BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 20 | C | PEPTO BISMOL /00139305/ | 2 | UNK | 0 | ||||||||||||
| 116210362 | 11621036 | 21 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 22 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 116210362 | 11621036 | 23 | C | KAOPECTATE /00235801/ | 2 | UNK | 0 | ||||||||||||
| 116210362 | 11621036 | 24 | C | MULTIVITAMIN /02371501/ | 2 | UNK, QD | 0 | QD | |||||||||||
| 116210362 | 11621036 | 25 | C | VITAMIN E /00110501/ | TOCOPHEROL | 1 | 400 UNITS, QD | 0 | 1 | DF | QD | ||||||||
| 116210362 | 11621036 | 26 | C | VITAMIN E /00110501/ | TOCOPHEROL | 1 | 400 UNITS, QD | 0 | 1 | DF | QD | ||||||||
| 116210362 | 11621036 | 27 | C | CINNAMON /01647501/ | CINNAMON | 1 | 500 MG, QD | 0 | 500 | MG | QD | ||||||||
| 116210362 | 11621036 | 28 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 MG, QD | 0 | 1000 | MG | QD | ||||||||
| 116210362 | 11621036 | 29 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 8000 UNITS, QD | 0 | 1 | DF | QD | ||||||||
| 116210362 | 11621036 | 30 | C | BIOTIN | BIOTIN | 1 | 7500 ?G, QD | 0 | 7500 | UG | QD | ||||||||
| 116210362 | 11621036 | 31 | C | ALEVE | NAPROXEN SODIUM | 1 | Oral | 2 TABLET, QD | 0 | TABLET | QD | ||||||||
| 116210362 | 11621036 | 32 | C | VICTOZA | LIRAGLUTIDE | 1 | 1.2 MG, QD | 0 | 1.2 | MG | QD | ||||||||
| 116210362 | 11621036 | 33 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116210362 | 11621036 | 1 | Hypertension |
| 116210362 | 11621036 | 2 | Hypertension |
| 116210362 | 11621036 | 4 | Hypertension |
| 116210362 | 11621036 | 5 | Hypertension |
| 116210362 | 11621036 | 6 | Hypertension |
| 116210362 | 11621036 | 7 | Hyperlipidaemia |
| 116210362 | 11621036 | 8 | Diabetes mellitus |
| 116210362 | 11621036 | 9 | Hypothyroidism |
| 116210362 | 11621036 | 11 | Autoimmune hepatitis |
| 116210362 | 11621036 | 12 | Hepatic enzyme increased |
| 116210362 | 11621036 | 13 | Product used for unknown indication |
| 116210362 | 11621036 | 14 | Product used for unknown indication |
| 116210362 | 11621036 | 15 | Diarrhoea |
| 116210362 | 11621036 | 16 | Product used for unknown indication |
| 116210362 | 11621036 | 17 | Product used for unknown indication |
| 116210362 | 11621036 | 18 | Product used for unknown indication |
| 116210362 | 11621036 | 19 | Product used for unknown indication |
| 116210362 | 11621036 | 20 | Product used for unknown indication |
| 116210362 | 11621036 | 21 | Product used for unknown indication |
| 116210362 | 11621036 | 22 | Product used for unknown indication |
| 116210362 | 11621036 | 23 | Product used for unknown indication |
| 116210362 | 11621036 | 24 | Supplementation therapy |
| 116210362 | 11621036 | 25 | Supplementation therapy |
| 116210362 | 11621036 | 27 | Supplementation therapy |
| 116210362 | 11621036 | 28 | Supplementation therapy |
| 116210362 | 11621036 | 29 | Supplementation therapy |
| 116210362 | 11621036 | 30 | Supplementation therapy |
| 116210362 | 11621036 | 31 | Pain |
| 116210362 | 11621036 | 32 | Diabetes mellitus |
| 116210362 | 11621036 | 33 | Blood potassium decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116210362 | 11621036 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116210362 | 11621036 | Cholelithiasis | |
| 116210362 | 11621036 | Chronic kidney disease | |
| 116210362 | 11621036 | Diverticulum | |
| 116210362 | 11621036 | Dizziness | |
| 116210362 | 11621036 | Fear of eating | |
| 116210362 | 11621036 | Gastrointestinal haemorrhage | |
| 116210362 | 11621036 | Haemorrhoids | |
| 116210362 | 11621036 | Insomnia | |
| 116210362 | 11621036 | Irritable bowel syndrome | |
| 116210362 | 11621036 | Large intestine polyp | |
| 116210362 | 11621036 | Malabsorption | |
| 116210362 | 11621036 | Rash pruritic | |
| 116210362 | 11621036 | Umbilical hernia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116210362 | 11621036 | 1 | 20050428 | 20050623 | 0 | |
| 116210362 | 11621036 | 2 | 20050405 | 20050427 | 0 | |
| 116210362 | 11621036 | 3 | 20050624 | 20130725 | 0 | |
| 116210362 | 11621036 | 4 | 2000 | 0 | ||
| 116210362 | 11621036 | 5 | 2009 | 0 | ||
| 116210362 | 11621036 | 6 | 200905 | 0 | ||
| 116210362 | 11621036 | 8 | 200802 | 0 | ||
| 116210362 | 11621036 | 9 | 201101 | 0 | ||
| 116210362 | 11621036 | 10 | 201101 | 0 | ||
| 116210362 | 11621036 | 11 | 200905 | 0 | ||
| 116210362 | 11621036 | 24 | 2009 | 0 | ||
| 116210362 | 11621036 | 25 | 2009 | 2012 | 0 | |
| 116210362 | 11621036 | 26 | 201501 | 0 | ||
| 116210362 | 11621036 | 27 | 2009 | 0 | ||
| 116210362 | 11621036 | 28 | 201406 | 0 | ||
| 116210362 | 11621036 | 29 | 201202 | 0 | ||
| 116210362 | 11621036 | 32 | 201508 | 0 |